Since July 1, 2026, Medicare has covered a $50-per-month copay for GLP-1 weight-loss medications. The policy is widely called the “GLP-1 Bridge.” If you’re on Medicare, or helping a parent who is, and you’re looking at semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound), or another GLP-1 for weight management, this article walks through what the program covers, what it doesn’t, and what to expect on the next pharmacy bill.
Note: This article covers Medicare policy as of its July 1, 2026 effective date. It is not medical or legal advice. Talk to your doctor about whether a GLP-1 medication is right for you, and contact Medicare or your Part D plan for questions specific to your coverage.
What is the Medicare GLP-1 Bridge?
The Medicare GLP-1 Bridge is a federal cost-sharing mechanism that caps what most Medicare Part D enrollees pay out-of-pocket for covered GLP-1 obesity medications at $50 per month. Before this policy, GLP-1 drugs used for weight loss weren’t covered by Medicare at all. The Inflation Reduction Act’s 2023 drug negotiation provisions and subsequent rulemaking opened the door for coverage, and the Bridge is the first direct cost-sharing limit applied to this drug class.
So if your Part D plan covers your GLP-1 prescription and you meet Medicare’s eligibility criteria, you pay a flat $50 copay at the pharmacy each month instead of a percentage of the drug’s list price, which can exceed $1,000/month for brand-name GLP-1s.
That’s a real saving for many people. But there are limits you need to understand before you count on this number.
What the $50 Bridge does NOT count toward
This is the detail that surprises most people:
The $50 monthly copay does not count toward your Part D deductible, and it does not count toward the $2,100 annual out-of-pocket cap.
Here’s what that means in practice.
| Medicare Part D threshold (2026) | Does the $50 GLP-1 Bridge copay count toward it? |
|---|---|
| Annual deductible (up to $590 in 2026) | No |
| $2,100 out-of-pocket cap | No |
| Catastrophic phase spending | No |
Why does this matter?
If you have other Part D-covered medications, like blood pressure drugs, cholesterol medication, or diabetes supplies, you still pay normal cost-sharing on those as you work through your deductible and toward the $2,100 cap. The $50 GLP-1 copay sits in a separate, fixed lane. It doesn’t move you any faster through the coverage phases for your other medications.
If your GLP-1 medication is the only prescription drug you take, this distinction matters less. But if you’re one of the many Medicare beneficiaries managing multiple chronic conditions, don’t assume your total out-of-pocket spending stops at $50/month. You may reach the $2,100 cap through other drug spending, and separately pay $50/month for your GLP-1 on top of that.
If you receive the Low-Income Subsidy (LIS / Extra Help)
Medicare’s Low-Income Subsidy, also called Extra Help, normally reduces or eliminates Part D cost-sharing for qualifying beneficiaries. Full LIS recipients typically pay $0–$3 per prescription.
The GLP-1 Bridge changes this for GLP-1 medications specifically. Under the Bridge program, LIS recipients will not receive their usual $0–$3 cost-sharing for GLP-1 obesity drugs. They’ll pay the same $50/month copay that applies to standard Part D enrollees.
That’s a meaningful change for people on fixed incomes who rely on Extra Help to keep medication costs manageable. If you currently receive LIS benefits and want to start a GLP-1 medication after July 1, plan for a $50/month expense that your Extra Help benefit won’t offset.
Who qualifies for LIS? Generally, people with limited income and resources. Medicaid dual-eligibles and SSI recipients are automatically enrolled. If you’re not sure whether you qualify, your local State Health Insurance Assistance Program (SHIP) counselor can check at no cost.
The Bridge is already in effect — here’s your checklist
The Bridge took effect July 1, 2026, so these prices apply now. If you or someone you care for is starting or continuing a GLP-1, run through this:
- Call your Part D plan and confirm your specific medication (Wegovy, Zepbound, etc.) is covered under the Bridge.
- Review your plan’s formulary. Not every GLP-1 is on every plan’s covered drug list.
- Ask about the LIS impact if you receive Extra Help, so you can budget for the $50 copay.
- Check for manufacturer savings programs. Some drugmakers offer separate patient assistance programs that may stack with or replace what Medicare provides. Your pharmacist or doctor’s office can often help you sort through these.
What Traqr users on Medicare should expect
If you track your GLP-1 medications and weight progress in Traqr, here’s what changes and what stays the same.
What’s different now that the Bridge is live:
- Your pharmacy cost for a covered GLP-1 under Part D is the flat $50 Bridge copay.
- If you log medication costs in Traqr, set your cost entry to the $50/month figure.
- If you’re on LIS/Extra Help, expect the $50 copay instead of your usual low or zero copay, and update your cost tracking to match.
What stays the same:
- Traqr’s medication logging, weight tracking, and weekly summary features work the same regardless of your insurance or copay amount.
- You can use Traqr’s notes field to record any pharmacy conversations or plan confirmations so you have a reference when billing questions come up.
If you’re newly eligible for a GLP-1 because of this coverage change, our guide to starting GLP-1s on Medicaid in 2026 covers the first weeks on medication — most of the “what the first month feels like” advice applies whatever your coverage.
Quick-reference summary
- What: $50/month flat copay for covered GLP-1 obesity drugs under Medicare Part D
- When: In effect since July 1, 2026
- Does it count toward your deductible? No
- Does it count toward the $2,100 out-of-pocket cap? No
- LIS / Extra Help recipients: Pay $50/month — usual $0–$3 cost-sharing does not apply to this drug class under the Bridge
- Action item: Call your Part D plan to confirm your specific drug is covered under the Bridge
Have a question about Medicare coverage or GLP-1 costs not answered here? Download Traqr to track your progress, and check back — we’ll update this page as CMS releases additional guidance.